Page last updated: 2024-08-26

vinpocetine and Stroke

vinpocetine has been researched along with Stroke in 24 studies

Research

Studies (24)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's13 (54.17)29.6817
2010's10 (41.67)24.3611
2020's1 (4.17)2.80

Authors

AuthorsStudies
Panda, P; Panda, PK; Ramachandran, A; Sharawat, IK1
Chen, J; Gong, Z; Hao, J; Liu, S; Ma, X; Shi, FD; Wei, C; Yan, C; Yao, Y; Zang, D; Zhang, F1
Dan, Y; Li, C; Liu, Y; Lu, QL; Song, G; Xu, MS; Yin, Y1
Chandra, A; Cheng, Z; Ding, Y; Du, H; Geng, X; Tong, Y; Zhu, H1
Yang, L; Zhang, L1
Hu, H; Huang, Y; Kong, Y; Li, C; Li, Y; Nao, J; Song, Y; Tan, L; Zhang, J; Zhang, W1
Il'ves, AG; Kataeva, GV; Pozdniakov, AV; Prakhova, LN; Stoliarov, ID1
Medhi, B; Modi, M; Patyar, S; Prakash, A1
Gulyas, B; Halldin, C; Hillert, J; Kostulas, K; Shchukin, E; Toth, M; Vas, A1
Airaksinen, A; Gulyás, B; Halldin, C; Hillert, J; Kostulas, K; Lindström, P; Schain, M; Tóth, M; Vas, A1
Balogh, A; Fehér, G; Késmárky, G; Misnyovszky, M; Nagy, K; Németh, G; Németh, GY; Szapáry, L; Tóth, K; Tóth, T1
Azimova, IuE; Tabeeva, GR1
Dézsi, L; Kárpáti, E; Kis-Varga, I; Komlódi, Z; Nagy, J1
Balkay, L; Bereczki, D; Bönöczk, P; Boros, I; Csiba, L; Emri, M; Fekete, I; Galuska, L; Gulyás, B; Kerényi, L; Lehel, S; Márián, T; Molnár, T; Nagy, Z; Szakáll, S; Szilágyi, G; Trón, L; Varga, J; Vas, A1
Gaĭkova, ON; Ianishevskiĭ, SN; Onishchenko, LS1
Bagoly, E; Fehér, G; Szapáry, L1
Valikovics, A1
Gaikova, ON; Onishchenko, LS; Yanishevskii, SN1
Bereczki, D; Fekete, I2
Balkay, L; Bereczki, D; Bönöczk, P; Boros, I; Csiba, L; Emri, M; Fekete, I; Galuska, L; Gulyás, B; Kerényi, L; Lehel, S; Márián, T; Molnár, T; Szakáll, S; Trón, L; Varga, J; Vas, A1
Doronin, BM; Feigin, VL; Gribatcheva, EV; Popova, TF; Tchervov, DV1
Bönöczk, P; Nagy, Z; Panczel, G1

Reviews

9 review(s) available for vinpocetine and Stroke

ArticleYear
Safety and Efficacy of Vinpocetine as a Neuroprotective Agent in Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
    Neurocritical care, 2022, Volume: 37, Issue:1

    Topics: Humans; Ischemic Stroke; Neuroprotective Agents; Randomized Controlled Trials as Topic; Stroke; Vinca Alkaloids

2022
Vinpocetine in the treatment of poststroke cognitive dysfunction: A protocol for systematic review and meta-analysis.
    Medicine, 2019, Volume: 98, Issue:6

    Topics: Cognitive Dysfunction; Humans; Nootropic Agents; Quality of Life; Randomized Controlled Trials as Topic; Research Design; Stroke; Vinca Alkaloids

2019
Anti-inflammatory effects of vinpocetine in atherosclerosis and ischemic stroke: a review of the literature.
    Molecules (Basel, Switzerland), 2014, Dec-26, Volume: 20, Issue:1

    Topics: Anti-Inflammatory Agents; Atherosclerosis; Brain Ischemia; Humans; Stroke; Vinca Alkaloids

2014
Role of vinpocetine in cerebrovascular diseases.
    Pharmacological reports : PR, 2011, Volume: 63, Issue:3

    Topics: Animals; Brain Ischemia; Cerebrovascular Disorders; Humans; Memory; Neuroprotective Agents; Nootropic Agents; Stroke; Vinca Alkaloids

2011
[Vinpocetin in neurological diseases].
    Ideggyogyaszati szemle, 2012, Nov-30, Volume: 65, Issue:11-12

    Topics: Animals; Anticonvulsants; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Cognition; Cognition Disorders; Dementia, Vascular; Hemorheology; Humans; Microcirculation; Nervous System Diseases; Neuroprotective Agents; Stroke; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids

2012
Vinpocetine. Monograph.
    Alternative medicine review : a journal of clinical therapeutic, 2002, Volume: 7, Issue:3

    Topics: Alzheimer Disease; Brain Ischemia; Calcium Channel Blockers; Hearing Disorders; Humans; Neuroprotective Agents; Nootropic Agents; Randomized Controlled Trials as Topic; Stroke; Vasodilator Agents; Vinca Alkaloids

2002
[The role of vinpocetine in the treatment of cerebrovascular diseases based in human studies].
    Orvosi hetilap, 2007, Jul-22, Volume: 148, Issue:29

    Topics: Acute Disease; Brain Ischemia; Cerebrovascular Circulation; Cerebrovascular Disorders; Chronic Disease; Glucose; Hemorheology; Humans; Neuroprotective Agents; Nootropic Agents; Quality of Life; Stroke; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids

2007
Vinpocetine for acute ischaemic stroke.
    The Cochrane database of systematic reviews, 2008, Jan-23, Issue:1

    Topics: Brain Ischemia; Calcium Channel Blockers; Humans; Neuroprotective Agents; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Vasodilator Agents; Vinca Alkaloids

2008
Vinpocetine for acute ischaemic stroke.
    The Cochrane database of systematic reviews, 2000, Issue:2

    Topics: Brain Ischemia; Calcium Channel Blockers; Humans; Neuroprotective Agents; Platelet Aggregation Inhibitors; Stroke; Vasodilator Agents; Vinca Alkaloids

2000

Trials

8 trial(s) available for vinpocetine and Stroke

ArticleYear
Low dose concomitant treatment with chlorpromazine and promethazine is safe in acute ischemic stroke.
    Journal of neurosurgical sciences, 2019, Volume: 63, Issue:3

    Topics: Adult; Aged; Aspirin; Atorvastatin; Chlorpromazine; Double-Blind Method; Drug Therapy, Combination; Edaravone; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Neuroprotective Agents; Platelet Aggregation Inhibitors; Promethazine; Stroke; Vinca Alkaloids

2019
Efficacy and Safety of Vinpocetine as Part of Treatment for Acute Cerebral Infarction: A Randomized, Open-Label, Controlled, Multicenter CAVIN (Chinese Assessment for Vinpocetine in Neurology) Trial.
    Clinical drug investigation, 2016, Volume: 36, Issue:9

    Topics: Aged; Anticoagulants; Aspirin; Cerebral Infarction; Cerebrovascular Circulation; China; Clopidogrel; Cognition; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Neuropsychological Tests; Platelet Aggregation Inhibitors; Quality of Life; Stroke; Ticlopidine; Ultrasonography, Doppler, Transcranial; Vinca Alkaloids

2016
[The multimodal strategy for the neuroprotection in stroke: results of the Russian multicenter clinical-epidemiological program SOKOL].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2012, Volume: 112, Issue:12 Pt 2

    Topics: Administration, Oral; Adult; Aged; Antihypertensive Agents; Cytoprotection; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neuroprotective Agents; Russia; Stroke; Treatment Outcome; Vinca Alkaloids

2012
Effects of vinpocetine on the redistribution of cerebral blood flow and glucose metabolism in chronic ischemic stroke patients: a PET study.
    Journal of the neurological sciences, 2005, Mar-15, Volume: 229-230

    Topics: Brain Chemistry; Cerebrovascular Circulation; Chronic Disease; Double-Blind Method; Female; Functional Laterality; Glucose; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Stroke; Ultrasonography, Doppler, Transcranial; Vinca Alkaloids

2005
[Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions].
    Ideggyogyaszati szemle, 2007, Jul-30, Volume: 60, Issue:7-8

    Topics: Administration, Oral; Adult; Blood Flow Velocity; Brain Ischemia; Cerebrovascular Circulation; Cognition; Cognition Disorders; Dementia, Vascular; Female; Humans; Male; Middle Aged; Middle Cerebral Artery; Neuroprotective Agents; Nootropic Agents; Pilot Projects; Psychometrics; Severity of Illness Index; Stroke; Ultrasonography, Doppler, Transcranial; Vasodilator Agents; Vinca Alkaloids

2007
[The effect of a single-dose intravenous vinpocetine on brain metabolism in patients with ischemic stroke].
    Orvosi hetilap, 2001, Mar-04, Volume: 142, Issue:9

    Topics: Aged; Brain; Brain Ischemia; Glucose; Humans; Infusions, Intravenous; Middle Aged; Neuroprotective Agents; Stroke; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Vasodilator Agents; Vinca Alkaloids

2001
Vinpocetine treatment in acute ischaemic stroke: a pilot single-blind randomized clinical trial.
    European journal of neurology, 2001, Volume: 8, Issue:1

    Topics: Acute Disease; Aged; Brain Ischemia; Dextrans; Drug Combinations; Feasibility Studies; Female; Humans; Male; Middle Aged; Molecular Weight; Neuroprotective Agents; Pilot Projects; Severity of Illness Index; Single-Blind Method; Stroke; Treatment Outcome; Vinca Alkaloids

2001
Vinpocetine increases cerebral blood flow and oxygenation in stroke patients: a near infrared spectroscopy and transcranial Doppler study.
    European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology, 2002, Volume: 15, Issue:1-2

    Topics: Aged; Cerebrovascular Circulation; Female; Humans; Male; Oxygen Consumption; Spectroscopy, Near-Infrared; Stroke; Ultrasonography, Doppler, Transcranial; Vasodilator Agents; Vinca Alkaloids

2002

Other Studies

7 other study(ies) available for vinpocetine and Stroke

ArticleYear
Vinpocetine Inhibits NF-κB-Dependent Inflammation in Acute Ischemic Stroke Patients.
    Translational stroke research, 2018, Volume: 9, Issue:2

    Topics: Adult; Aged; Brain Ischemia; C-Reactive Protein; Cytokines; Female; Follow-Up Studies; Gene Expression Regulation; Humans; Inflammation; Leukocytes, Mononuclear; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuroprotective Agents; NF-kappa B; RNA, Messenger; Statistics, Nonparametric; Stroke; Time Factors; Vinca Alkaloids

2018
[Positron-emission tomography in the diagnosis of middle cerebral artery lesions].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2009, Volume: 109, Issue:12 Suppl 2

    Topics: Aged; Glucose; Humans; Infusions, Intravenous; Male; Middle Aged; Middle Cerebral Artery; Neuroprotective Agents; Positron-Emission Tomography; Prognosis; Stroke; Vinca Alkaloids

2009
Visualising neuroinflammation in post-stroke patients: a comparative PET study with the TSPO molecular imaging biomarkers [11C]PK11195 and [11C]vinpocetine.
    Current radiopharmaceuticals, 2012, Volume: 5, Issue:1

    Topics: Aged; Binding Sites; Biomarkers; Carbon Radioisotopes; Encephalitis; Humans; Isoquinolines; Male; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, GABA; Stroke; Vinca Alkaloids; Young Adult

2012
Evolution of microglial activation in ischaemic core and peri-infarct regions after stroke: a PET study with the TSPO molecular imaging biomarker [((11))C]vinpocetine.
    Journal of the neurological sciences, 2012, Sep-15, Volume: 320, Issue:1-2

    Topics: Adult; Aged; Biomarkers; Brain Ischemia; Carbon Radioisotopes; Functional Neuroimaging; Humans; Infarction; Magnetic Resonance Imaging; Male; Microglia; Middle Aged; Molecular Imaging; Organ Size; Positron-Emission Tomography; Radioligand Assay; Receptors, GABA; Stroke; Time Factors; Up-Regulation; Vinca Alkaloids

2012
[Neuroprotective effects of vinpocetine in vivo and in vitro. Apovincaminic acid derivatives as potential therapeutic tools in ischemic stroke].
    Acta pharmaceutica Hungarica, 2002, Volume: 72, Issue:2

    Topics: Animals; Brain Ischemia; Disease Models, Animal; Humans; Ischemic Attack, Transient; Neuroprotective Agents; Rats; Stroke; Structure-Activity Relationship; Vinca Alkaloids

2002
[Changes in the focus of experimental ischemic stroke under the influence of neuroprotective drugs].
    Morfologiia (Saint Petersburg, Russia), 2006, Volume: 130, Issue:6

    Topics: Amino Acids; Animals; Brain; Brain Ischemia; Glycerylphosphorylcholine; Male; Neuroprotective Agents; Nootropic Agents; Piracetam; Rats; Stroke; Vinca Alkaloids

2006
Changes at the focus of experimental ischemic stroke treated with neuroprotective agents.
    Neuroscience and behavioral physiology, 2008, Volume: 38, Issue:1

    Topics: Amino Acids; Animals; Brain; Brain Ischemia; Glycerylphosphorylcholine; Male; Neuroprotective Agents; Nootropic Agents; Piracetam; Rats; Recovery of Function; Stroke; Vinca Alkaloids

2008